Expectations regarding the vaccine have also increased amidst increasing cases of coronaviruses. According to the World Health Organization (WHO) vaccine tracker, there are now 29 vaccines undergoing human trials. At the same time, 138 vaccines are undergoing pre-clinical testing. China's state-owned Sinofarm claims that its vaccine will come on the market by December.
Indigenous vaccine manufacturers Bharat Biotech-ICMR and Zydus Cadila Vaccine Phase-2 have entered the human trials. At the same time, there are reports that KoviShield made of Oxford-AstraZeneca will be available in India first. Serum Institute of India has obtained permission for Phase-2 and Phase-3 Human Trials in India.
First of all, China's vaccine ... Sinopharm vaccine will be available in December
The vaccine produced by Canon Biologics in China has received a patent. The document, published on the website of China's National Intellectual Property Administration, claimed that the vaccine could be mass-produced in an outbreak.
The patent was issued on August 11, according to a report by the Chinese state-run People's Daily. On the same day, Russian President Vladimir Putin announced the registration of the Russian vaccine "Sputnik-V".
At the same time, the vaccine being developed by the Wuhan Institute of Biological Products of China will be commercially available in December. The head of Sinopharm, the company making it, said that phase-3 trials of the vaccine are moving in the right direction.
Sinopharm vaccine will come to 1,000 yuan i.e. about 10,800 rupees. It is of two doses. Which will be given in a gap of 28 days. One dose of this gives protection for up to 97% against the corona, while protection is 100% when the second dose is applied.
This vaccine from Sinopharm has been successful in Phase-1/2 trials. Its phase-3 trials are going on. Tests so far have shown that strong antibody response has been found after applying the vaccine.
What is happening to the indigenous vaccine?
India has completed Biotech Kovacine and Zydus Cadila Vaccine Phase-1. Its phase-2 human trials have started. According to the WHO tracker, work is going on at a fast pace. But the vaccine will come in the market only next year.
At the same time, the Serum Institute of India has obtained permission for the Phase-2 and Phase-3 trials of the Kovyshield vaccine of Oxford-AstraZeneca in India. For this, hospitals have appealed to Volunteers to come forward.
However, the good thing is that its Phase-3 has already started in the UK, US, and Brazil. That is, even if we do not get the results of trials, the Serum Institute will start making it. This vaccine will be available in India for Rs 225.
WHO'S DOING?
WHO has launched the Kovacs Global Vaccine Facility Program. It has been designed by the WHO to raise funds from rich countries and non-profits. So that two billion effective vaccines can be delivered, supporting the worldwide vaccine development program.
The deadline of 31 August has been set to join this program. The Gavi Vaccine Alliance and the Coalition for Epidemic Preparedness Innovations are also associated with the program along with WHO.
Kovacs is part of a larger program, called the Access to Covid-19 Tools (ACT) accelerator. It ensures vaccines, treatment, diagnostic tests, and other healthcare resources to fight epidemics.
The United States, the UK, Japan, and the European Union have spent billions of dollars dealing with vaccine manufacturers. The United States alone has developed $ 11 billion in deals to develop and deliver the vaccine.
DRDO: DRDO successfully tests state-of-the-art unmanned aircraft, knows the special features of Tapas UAV
Tapas Unmanned Aerial Vehicle (UAV) has completed 18 hours of flight testing. It has been designed and developed by the Aeronautical Development Establishment (ADE), the premier research laboratory of
Cryptocurrency: Crypto market crashed again, more than 15 percent have broken bitcoin so far this year, know the latest situation
The market for cryptocurrencies is considered volatile and risky. Here is one moment a man reaches the heights of the sky, then in the next moment he falls on the ground in a jiffy. Crypto investors
Indian Passport: Only 7.20 percent of the country's citizens have passports, the figure will touch 10 crores in a few months
7.20 percent of the citizens of the country have passports. By the middle of December, passports of 9.6 crore people had been made. Most of these passports have been made in the last decade. This
PM Modi: 'We stand shoulder to shoulder in the fight against terrorism', PM Modi told the President of Paraguay
Prime Minister Narendra Modi held a bilateral meeting with Paraguay's President Santiago Pena Palacios at Hyderabad House in Delhi. During this, Prime Minister Modi said, 'Your visit is very historic.
Chernobyl Nuclear Disaster: 36 years ago, Chernobyl nuclear disaster happened, know its scary history
The war between Russia and Ukraine (Russia Ukraine War News) has taken a dangerous turn. Russian President Vladimir Putin has ordered Russian nuclear forces to be on high alert. Now after this alert,
Joe Biden forgives thousands of people guilty of possessing marijuana, a major change in America's drug policy
US President Joe Biden has made a big change in the country's policy regarding marijuana. He has waived the sentences of thousands of people convicted under federal law for drug possession. However,
Remdesivir injections were sold for 45 thousand, three arrested including women
Gurugram The game of black marketing of Remdesivir injection is going on indiscriminately in the city. Max and Narayana three employees of the hospital were involved in this black marketing. Police
Weather Update: Heat wave likely in UP-Rajasthan, the temperature may increase in Delhi; There will be heavy rain alert in these states
Pre-monsoon rains are continuing in many states of the country, while in some states, the possibility of re-creation of heatwave conditions has started. With the end of the storm and rain in the
JEE Main 2022: The application process for JEE Main June 2022 resumed, you can register till this date
JEE Main 2022 Application: The National Testing Agency (NTA) has resumed the application process for the Main Joint Entrance Examination i.e. JEE Main for the June 2022 session. Applicants who want to
Alia Bhatt : Alia Bhatt received a memorable gift on Mother's Day, mother Soni wished by sharing unseen photos
Bollywood's cute and talented actress Alia Bhatt is not dependent on any introduction today. Mother's Day was celebrated in the UK on Sunday and on this occasion, mother Soni Razdan shared an unseen
